» Articles » PMID: 23462821

Suggestions on the Use of Statistical Methodologies in Studies of the European Group for Blood and Marrow Transplantation

Overview
Specialty General Surgery
Date 2013 Mar 7
PMID 23462821
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

This document explains some of the relevant methodological issues involved in planning a clinical study using survival and time-to-event outcome data, particularly in the field of haematopoietic stem cell transplantation, and indicates the appropriate statistical methods to use for the analysis. As the majority of these methods are commonly used in survival and event-history analysis, this document discusses their potential and limitations with reference to common SCT research situations. Some reference is given to methods, recently appearing in the literature that may be capable of handling complex investigations. These guidelines also address various practical issues, such as recoding or transforming variables in regression models or reporting results.

Citing Articles

COVID-19 prior to hematopoietic stem cell transplantation increases the risk of acute graft-versus-host disease but does not affect overall mortality.

Randi B, Higashino H, Ponzio V, Abdala E, Guimaraes T, Vasques F Bone Marrow Transplant. 2025; .

PMID: 39984749 DOI: 10.1038/s41409-025-02536-y.


Risk Factors and Long-Term Outcomes of Acute Kidney Disease in Hematopoietic Stem Cell Transplant-Cohort Study.

Rodrigues N, Branco C, Sousa G, Silva M, Costa C, Marques F Cancers (Basel). 2025; 17(3).

PMID: 39941904 PMC: 11816487. DOI: 10.3390/cancers17030538.


Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.

Steiner N, Massoud R, Richter J, Perekhrestenko T, Gagelmann N, Niederwieser C Eur J Haematol. 2024; 114(1):79-88.

PMID: 39300830 PMC: 11613535. DOI: 10.1111/ejh.14305.


Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.

Gross S, Ihlow J, Busack L, Adamiak K, Schrezenmeier J, Jesse J Blood Cancer J. 2024; 14(1):160.

PMID: 39284846 PMC: 11405931. DOI: 10.1038/s41408-024-01140-5.


Early autologous and/or allogeneic stem cell transplantation for adult patients with advanced stage T- lymphoblastic leukemia/lymphoma or Burkitt lymphoma. A retrospective single-centre analysis.

Steiner N, Baier K, Ritter D, Rudzki J, Hetzenauer G, Kock S Ann Hematol. 2024; 103(11):4701-4705.

PMID: 39225777 PMC: 11534969. DOI: 10.1007/s00277-024-05979-3.